Sera Prognostics (SERA) Competitors $2.60 -0.15 (-5.45%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$3.08 +0.48 (+18.27%) As of 08/7/2025 06:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SERA vs. TALK, AIRS, TOI, EHAB, VMD, XGN, DCGO, EUDA, QIPT, and CORBFShould you be buying Sera Prognostics stock or one of its competitors? The main competitors of Sera Prognostics include Talkspace (TALK), AirSculpt Technologies (AIRS), Oncology Institute (TOI), Enhabit (EHAB), Viemed Healthcare (VMD), Exagen (XGN), DocGo (DCGO), EUDA Health (EUDA), Quipt Home Medical (QIPT), and Global Cord Blood (CORBF). These companies are all part of the "healthcare" industry. Sera Prognostics vs. Its Competitors Talkspace AirSculpt Technologies Oncology Institute Enhabit Viemed Healthcare Exagen DocGo EUDA Health Quipt Home Medical Global Cord Blood Talkspace (NASDAQ:TALK) and Sera Prognostics (NASDAQ:SERA) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership, media sentiment and dividends. Which has better valuation & earnings, TALK or SERA? Talkspace has higher revenue and earnings than Sera Prognostics. Sera Prognostics is trading at a lower price-to-earnings ratio than Talkspace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTalkspace$187.59M2.20$1.15M$0.02123.50Sera Prognostics$115K851.74-$32.90M-$0.85-3.06 Which has more risk and volatility, TALK or SERA? Talkspace has a beta of 1.06, indicating that its share price is 6% more volatile than the S&P 500. Comparatively, Sera Prognostics has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500. Do analysts recommend TALK or SERA? Talkspace currently has a consensus target price of $4.50, indicating a potential upside of 82.19%. Given Talkspace's stronger consensus rating and higher probable upside, analysts plainly believe Talkspace is more favorable than Sera Prognostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Talkspace 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.00Sera Prognostics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders & institutionals have more ownership in TALK or SERA? 57.4% of Talkspace shares are held by institutional investors. Comparatively, 54.6% of Sera Prognostics shares are held by institutional investors. 23.5% of Talkspace shares are held by insiders. Comparatively, 13.5% of Sera Prognostics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media favor TALK or SERA? In the previous week, Talkspace had 9 more articles in the media than Sera Prognostics. MarketBeat recorded 15 mentions for Talkspace and 6 mentions for Sera Prognostics. Sera Prognostics' average media sentiment score of 0.43 beat Talkspace's score of 0.32 indicating that Sera Prognostics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Talkspace 3 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Sera Prognostics 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is TALK or SERA more profitable? Talkspace has a net margin of 1.41% compared to Sera Prognostics' net margin of -30,306.48%. Talkspace's return on equity of 2.47% beat Sera Prognostics' return on equity.Company Net Margins Return on Equity Return on Assets Talkspace1.41% 2.47% 2.09% Sera Prognostics -30,306.48%-49.78%-36.40% SummaryTalkspace beats Sera Prognostics on 15 of the 17 factors compared between the two stocks. Get Sera Prognostics News Delivered to You Automatically Sign up to receive the latest news and ratings for SERA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SERA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SERA vs. The Competition Export to ExcelMetricSera PrognosticsMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$103.60M$7.12B$5.48B$9.57BDividend YieldN/A2.83%3.99%4.18%P/E Ratio-3.0662.8629.8725.14Price / Sales851.7426.87422.9397.17Price / CashN/A26.5935.9458.58Price / Book1.8617.548.105.59Net Income-$32.90M$239.96M$3.26B$265.48M7 Day Performance-3.70%1.08%0.64%1.22%1 Month Performance-4.41%-3.72%2.42%0.39%1 Year Performance-64.91%22.84%27.60%23.47% Sera Prognostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SERASera Prognostics0.5172 of 5 stars$2.60-5.5%N/A-64.9%$103.60M$115K-3.06120News CoverageEarnings ReportGap DownTALKTalkspace3.6838 of 5 stars$2.36+2.2%$4.50+90.7%+46.2%$386.50M$187.59M118.06500Earnings ReportAnalyst RevisionAIRSAirSculpt Technologies0.7675 of 5 stars$6.03+2.0%$3.75-37.8%+60.6%$347.68M$180.35M-24.12240Earnings ReportGap UpTOIOncology Institute2.1412 of 5 stars$4.03+8.0%$7.00+73.7%+766.7%$332.84M$403.15M-5.76660Upcoming EarningsGap UpEHABEnhabit2.2157 of 5 stars$6.64+1.8%$8.75+31.9%-8.2%$330.16M$1.03B-2.4010,700News CoverageEarnings ReportGap UpVMDViemed Healthcare2.7807 of 5 stars$6.07+2.4%N/A+6.6%$234.38M$224.26M20.231,179Earnings ReportXGNExagen4.5524 of 5 stars$8.85+2.5%$11.25+27.1%+266.9%$189.89M$55.64M-9.94220Gap UpDCGODocGo2.7381 of 5 stars$1.40+5.3%$3.56+154.3%-53.5%$135.64M$520.50M-70.004,407News CoveragePositive NewsEarnings ReportEUDAEUDA Health1.2231 of 5 stars$3.03-4.1%N/A-26.5%$117.60M$4.01M0.002News CoveragePositive NewsGap DownQIPTQuipt Home Medical2.5199 of 5 stars$2.41+4.3%$2.85+18.3%-35.0%$100.36M$245.91M-11.481,200Upcoming EarningsCORBFGlobal Cord BloodN/A$0.71flatN/A-10.0%$86.30M$196.12M0.001,200Gap Up Related Companies and Tools Related Companies TALK Competitors AIRS Competitors TOI Competitors EHAB Competitors VMD Competitors XGN Competitors DCGO Competitors EUDA Competitors QIPT Competitors CORBF Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SERA) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredThe Day Silicon DiesThe Day China Left America's Supercomputers in the Dust In 200 seconds, China's quantum computer accomplish...The Oxford Club | SponsoredThis accelerated income plan is solving American's #1 retirement fearThe #1 fear in retirement today? Running out of money. That’s why income expert Tim Plaehn created a simple...Investors Alley | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sera Prognostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sera Prognostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
